Who
Lorence H. Kim
Director
Company insider
Files Form 4 as: Director, Revolution Medicines; Director, Cencora; Director, Cowen; Chief Financial Officer, Moderna; Director, Seres Therapeutics.
In numbers
- Trades disclosed
- 131
- Buys
- 2
- Sells
- 18
- Bought
- $1.9M
- Sold
- $101.6M
- Companies
- 5
- Companies where not an officer
- 4
- First trade
- 25 Jun 2015
- Last trade
- 8 Sep 2026
- Last filed
- 10 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Sep 2026filed 10 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $146K706 at $206.60 | filing |
| 8 Sep 2026filed 10 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $207K999 at $207.33 | filing |
| 8 Sep 2026filed 10 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $748K3,587 at $208.55 | filing |
| 8 Sep 2026filed 10 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $598K2,853 at $209.56 | filing |
| 8 Sep 2026filed 10 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $996K4,730 at $210.50 | filing |
| 8 Sep 2026filed 10 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $812K3,844 at $211.36 | filing |
| 8 Sep 2026filed 10 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $79K371 at $212.27 | filing |
| 8 Sep 2026filed 10 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $146K706 at $206.60 | filing |
| 8 Sep 2026filed 10 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $207K999 at $207.33 | filing |
| 8 Sep 2026filed 10 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $748K3,587 at $208.55 | filing |
| 8 Sep 2026filed 10 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $598K2,853 at $209.56 | filing |
| 8 Sep 2026filed 10 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $996K4,730 at $210.50 | filing |
| 8 Sep 2026filed 10 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $812K3,844 at $211.36 | filing |
| 8 Sep 2026filed 10 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $79K371 at $212.27 | filing |
| 31 Aug 2026filed 2 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $60K300 at $200.56 | filing |
| 31 Aug 2026filed 2 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $1.3M6,597 at $201.47 | filing |
| 31 Aug 2026filed 2 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $2.6M12,919 at $202.48 | filing |
| 31 Aug 2026filed 2 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $5.3M26,160 at $203.55 | filing |
| 31 Aug 2026filed 2 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $1.5M7,271 at $204.35 | filing |
| 31 Aug 2026filed 2 Sep 2026 | RVMD Revolution MedicinesBiotechnology | SEC FORM 4 Sold | $437K2,128 at $205.19 | filing |
News
Revolution Medicines Presents Overall Survival Data for RASONQUE™ (daraxonrasib) Across Subgroups in Previously Treated Metastatic Pancreatic Cancer at ESMO 2026RVMD · manilatimes.net · 23 Oct 2026Contrasting Revolution Medicines (NASDAQ:RVMD) and Agios Pharmaceuticals (NASDAQ:AGIO)RVMD · themarketsdaily.com · 22 Oct 20263,946 Shares of Revolution Medicines, Inc. $RVMD Acquired by Vontobel Holding Ltd.RVMD · dailypolitical.com · 21 Oct 2026
0 headlines in the last 90 days name Lorence H. Kim; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.